DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE
摘要
The presently disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin and enzyme replacement therapy for the treatment of Fabry disease. The presently disclosed subject matter further provides a dosing regimen and administration schedule for the use of migalastat hydrochloride and agalsidase for the treatment of Fabry disease.
申请公布号
WO2012125402(A3)
申请公布日期
2014.05.01
申请号
WO2012US28260
申请日期
2012.03.08
申请人
AMICUS THERAPEUTICS, INC.;GREENE, DOUGLAS, STUART;VALENZANO, KENNETH, JOSEPH
发明人
GREENE, DOUGLAS, STUART;VALENZANO, KENNETH, JOSEPH